Azaclorzine

This classification denotes a vasodilating agent with the molecular formula C22H24ClN3OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7N4BHX8N3L, chemically known as 10h-phenothiazine, 2-chloro-10-(3-(hexahydropyrrolo(1,2-a)pyrazin-2(1h)-yl)-1-oxopropyl)- but generally known as azaclorzine, which bears US NIH Compound Identifier 39526. Azaclorzine most often comes in base and hydrochloride forms. European Medicines Agency schedules Azaclorzine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05625MIG. The term AZACLORZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). AZACLORZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule azaclorzine under HS 29343090 and SITC 51578. As of Q4 2014, AZACLORZINE remains the US FDA Preferred Term for this commodity. Azaclorzine bears US NLM identifiers UMLS ID C0028295 and NCI Concept Code C74421. SMILES: Clc1cc2N(C(=O)CCN3CC4N(CCC4)CC3)c3c(Sc2cc1)cccc3.